<DOC>
	<DOCNO>NCT00865514</DOCNO>
	<brief_summary>This project focus kinetics , metabolism human toxicology dichloroacetate ( DCA ) tyrosine catabolism . The hypothesis tyrosine metabolism great subject harbor KRT variant GSTz1/MAAI DCA exhibit high Km .</brief_summary>
	<brief_title>Pharmacotoxicology Trichloroethylene Metabolites</brief_title>
	<detailed_description>Specific Aim 4 . Quantify effect DCA human tyrosine metabolism biotransformation relation dose genotype .</detailed_description>
	<mesh_term>Trichloroethylene</mesh_term>
	<criteria>Adults schedule elective surgery benign liver disease . Normal EKG history Normal baseline lab Pregnancy severe anemia , define hematocrit &lt; 30 % . diabetes mellitus renal insufficiency , define serum creatinine &gt; 1.5 mg/dl creatinine clearance &lt; 60 ml/min elevate liver enzymes psychiatric illness require medication primary biliary cirrhosis form cirrhosis viral hepatitis nonviral steatohepatitis coronary heart disease , define require daily administration antianginal drug New York Heart Association Class III IV heart failure malignancy type anatomical location</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>dichloroacetate</keyword>
	<keyword>tyrosine</keyword>
	<keyword>maleylacetoacetate</keyword>
	<keyword>trichloroethylene</keyword>
	<keyword>leucine</keyword>
	<keyword>haplotype</keyword>
</DOC>